These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9147040)

  • 21. Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site.
    Shriver Z; Raman R; Venkataraman G; Drummond K; Turnbull J; Toida T; Linhardt R; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10359-64. PubMed ID: 10984531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function relations of antithrombin III-heparin interactions as assessed by biophysical and biological assays and molecular modeling of peptide-pentasaccharide-docked complexes.
    Tyler-Cross R; Sobel M; McAdory LE; Harris RB
    Arch Biochem Biophys; 1996 Oct; 334(2):206-13. PubMed ID: 8900394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.
    Desai UR; Petitou M; Björk I; Olson ST
    J Biol Chem; 1998 Mar; 273(13):7478-87. PubMed ID: 9516447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The signature 3-O-sulfo group of the anticoagulant heparin sequence is critical for heparin binding to antithrombin but is not required for allosteric activation.
    Richard B; Swanson R; Olson ST
    J Biol Chem; 2009 Oct; 284(40):27054-64. PubMed ID: 19661062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.
    Toida T; Hileman RE; Smith AE; Vlahova PI; Linhardt RJ
    J Biol Chem; 1996 Dec; 271(50):32040-7. PubMed ID: 8943254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Search for the heparin antithrombin III-binding site precursor.
    Linhardt RJ; Wang HM; Loganathan D; Bae JH
    J Biol Chem; 1992 Feb; 267(4):2380-7. PubMed ID: 1733939
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of heparin with internally quenched fluorogenic peptides derived from heparin-binding consensus sequences, kallistatin and anti-thrombin III.
    Pimenta DC; Nantes IL; de Souza ES; Le Bonniec B; Ito AS; Tersariol IL; Oliveira V; Juliano MA; Juliano L
    Biochem J; 2002 Sep; 366(Pt 2):435-46. PubMed ID: 12000310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparinase I acts on a synthetic heparin pentasaccharide corresponding to the antithrombin III binding site.
    Yu G; LeBrun L; Gunay NS; Hoppensteadt D; Walenga JM; Fareed J; Linhardt RJ
    Thromb Res; 2000 Dec; 100(6):549-56. PubMed ID: 11152935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A mechanism for heparin-induced potentiation of antithrombin III.
    van Boeckel CA; Grootenhuis PD; Visser A
    Nat Struct Biol; 1994 Jul; 1(7):423-5. PubMed ID: 7664058
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparin.
    Sisu E; Tripathy S; Mallet JM; Driguez PA; Hérault JP; Sizun P; Herbert JM; Petitou M; Sinay P
    Biochimie; 2003; 85(1-2):91-9. PubMed ID: 12765779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis of a 3-deoxy-L-iduronic acid containing heparin pentasaccharide to probe the conformation of the antithrombin III binding sequence.
    Lei PS; Duchaussoy P; Sizun P; Mallet JM; Petitou M; Sinaÿ P
    Bioorg Med Chem; 1998 Aug; 6(8):1337-46. PubMed ID: 9784873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modular synthesis of heparin oligosaccharides.
    Orgueira HA; Bartolozzi A; Schell P; Litjens RE; Palmacci ER; Seeberger PH
    Chemistry; 2003 Jan; 9(1):140-69. PubMed ID: 12506372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources.
    Loganathan D; Wang HM; Mallis LM; Linhardt RJ
    Biochemistry; 1990 May; 29(18):4362-8. PubMed ID: 2350542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis of heparin fragments: a methyl alpha-pentaoside with high affinity for antithrombin III.
    Petitou M; Duchaussoy P; Lederman I; Choay J; Jacquinet JC; Sinaÿ P; Torri G
    Carbohydr Res; 1987 Sep; 167():67-75. PubMed ID: 3690577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of new synthetic heparin mimetics on whole blood thrombin generation in vivo and in vitro in rats.
    Hérault JP; Bernat A; Gaich C; Herbert M
    Thromb Haemost; 2002 Feb; 87(2):238-44. PubMed ID: 11858483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An unusual antithrombin-binding heparin octasaccharide with an additional 3-O-sulfated glucosamine in the active pentasaccharide sequence.
    Guerrini M; Elli S; Mourier P; Rudd TR; Gaudesi D; Casu B; Boudier C; Torri G; Viskov C
    Biochem J; 2013 Jan; 449(2):343-51. PubMed ID: 23083208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Introducing a C-interglycosidic bond in a biologically active pentasaccharide hardly affects its biological properties.
    Petitou M; Hérault JP; Lormeau JC; Helmboldt A; Mallet JM; Sinaÿ P; Herbert JM
    Bioorg Med Chem; 1998 Sep; 6(9):1509-16. PubMed ID: 9801822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cleavage of the antithrombin III binding site in heparin by heparinases and its implication in the generation of low molecular weight heparin.
    Shriver Z; Sundaram M; Venkataraman G; Fareed J; Linhardt R; Biemann K; Sasisekharan R
    Proc Natl Acad Sci U S A; 2000 Sep; 97(19):10365-70. PubMed ID: 10984532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [(1)H,(15)N] HSQC NMR.
    Beecher CN; Manighalam MS; Nwachuku AF; Larive CK
    Anal Bioanal Chem; 2016 Feb; 408(6):1545-55. PubMed ID: 26758598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III.
    Atha DH; Lormeau JC; Petitou M; Rosenberg RD; Choay J
    Biochemistry; 1987 Oct; 26(20):6454-61. PubMed ID: 3427019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.